Related Experiment Video

Updated: Jun 16, 2026

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
06:07

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors

Published on: August 5, 2022

Aberrant methylation inactivates transforming growth factor Beta receptor I in head and neck squamous cell carcinoma

Teresita Muñoz-Antonia1, Mariclara Torrellas-Ruiz, Jonathan Clavell

  • 1Department of Interdisciplinary Oncology, Moffitt Cancer Center, Tampa, FL 33612, USA.

International Journal of Otolaryngology
|January 30, 2010
PubMed

Insights

Head and neck squamous cell carcinoma (HNSCC) frequently shows suppressed TGF-beta type I receptor (TbetaR-I) expression. This loss is primarily linked to DNA hypermethylation of the TbetaR-I gene promoter region.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Genetics

Background:

  • Transforming growth factor-beta (TGF-beta) signaling is crucial in cancer, with alterations common in head and neck squamous cell carcinoma (HNSCC).
  • While TGF-beta type II receptor (TbetaR-II) mutations are frequent in HNSCC, TbetaR-I mutations are rare, indicating other pathway disruptions.
  • Investigating TbetaR-I expression abnormalities is essential for understanding HNSCC pathogenesis.

Purpose of the Study:

  • To identify abnormalities in TGF-beta type I receptor (TbetaR-I) expression in HNSCC.
  • To correlate TbetaR-I expression changes with clinical-pathologic features.
  • To elucidate the molecular mechanisms underlying TbetaR-I dysregulation in HNSCC.

Main Methods:

  • Analysis of TbetaR-I expression in 50 HNSCC samples.
  • Evaluation of TbetaR-I hypermethylation using methylation-specific PCR (MSP) and MSRE.
  • Assessment of mutations, mRNA, and protein expression via sequencing, RT-PCR, and immunohistochemistry.

Main Results:

  • Loss of TbetaR-I expression was observed in 83% of HNSCC cases.
  • DNA hypermethylation of the TbetaR-I promoter region was identified in 62% of the tumors.
  • Rare mutations (9A/6A and Int7G24A) were detected in two patients.

Conclusions:

  • Suppression of TbetaR-I expression is a significant event in HNSCC.
  • DNA hypermethylation is the primary mechanism driving TbetaR-I loss in HNSCC.
  • These findings highlight the role of TbetaR-I dysregulation in HNSCC development.

More Related Videos

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Induction and Analysis of Epithelial to Mesenchymal Transition10:37

Induction and Analysis of Epithelial to Mesenchymal Transition

Published on: August 27, 2013

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...